Brilliant StarsBrilliant Stars🃏All Escavalier cards
Ask about Escavalier
Escavalier #101 Pokémon card from Brilliant Stars

Escavalier 101/172

Brilliant Stars

Find this card on eBay

Affiliate link · we may earn commission

Escavalier #101 from Brilliant Stars currently trades at $0.11 raw, with PSA 10 copies reaching $30.50 — a 277.3x grade premium.
Current Prices (USD)
Ungraded
$0.11
PSA 7
$10.27
PSA 8
$10.27
PSA 9
$10.27
PSA 10
$30.50
ACE 10
BGS 10 Black
$200.00
CGC 10 Pristine
$32.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Escavalier 101/172 from Brilliant Stars has a current raw market value of $0.11.

Current raw value
$0.11
PSA 9 value
$10.27
PSA 10 value
$30.50
View all cards from Brilliant Stars
Collector Intel
277.3x
Raw → PSA 10
High-risk grade
93.4x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 277x the raw price. The expected value accounts for the realistic probability.
$0
Buy Raw
~$25
Grading Fee
PSA Standard
$31
PSA 10 Value
+$5
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1093.4x raw
PSA 10$31277.3x raw

Frequently asked questions

How much is Escavalier #101 from Brilliant Stars worth?+
Escavalier #101 from Brilliant Stars is currently worth Raw: $0.11, PSA 9: $10.27, PSA 10: $30.50 based on recent sold listings. Prices update daily from real eBay sales.
Is Escavalier #101 worth grading?+
The PSA 10 price of $30.50 is 277.3× the raw price of $0.11. After a ~$25 grading fee, a PSA 10 result would net approximately $30.39 — assuming the card grades a 10.
Where do PokePrices Escavalier #101 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.